Time-Restricted Feeding Reduces the Detrimental Effects of a High-Fat Diet, Possibly by Modulating the Circadian Rhythm of Hepatic Lipid Metabolism and Gut Microbiota

Background

Time-restricted feeding (TRF), in some cases also referred as intermittent fasting, is a feeding pattern where all nutrient intake is restricted to certain hours of the day with no limitation on nutrient quality or quantity (1, 2). Studies in as early as 1980s proposed that reducing food availability protected against aging and improved life span in mice (3, 4). Recent researches as well as our studies in rodent animals concerning TRF are increasingly revealing its various beneficial effects, including preventing diet-induced obesity and its associated metabolic disorders (1, 5–8), preventing inflammatory bowel diseases and colorectal cancer and neurodegenerative disorders (9, 10), and alleviating hepatic ischemia reperfusion injury (11). The rhythm of feeding can greatly influence the development of liver steatosis and remodel the hepatic circadian metabolome, which suggests a potential mechanism of TRF (12, 13). By restricting food availability to a certain temporal window at the same time of every day, TRF can trigger a food-anticipatory activity depending on the endogenous circadian clock (14).

In mammals, the intrinsic circadian system is a complicated feedback network that maintains and regulates proper rhythms in metabolic pathways required for organism homeostasis (15, 16). Mammalian circadian clock contains a central oscillator located in the suprachiasmatic nuclei (SCN) of the hypothalamus and various peripheral tissue, with harmonious bidirectional interactions (17–19). The molecular bedrock of core circadian clock is composed of a series of diurnally fluctuated proteins, and among which the transcription factors CLOCK, BMAL1 (Brain and muscle Arnt-like protein-1), Cryptochrome (Cry1 and Cry2), and Period (Per1, Per2, and Per3) act as the core molecules (20, 21). In peripheral organs including liver, skeletal muscle, and adipose tissue, similar circadian rhythms also occur with feeding/fasting acting as the primary regulator (16, 18, 22). The core circadian molecule composed of CLOCK:BMAL1 complex is closely connected to cellular metabolism by regulating the cyclic transcription of Nampt (nicotinamide phosphoribosyl transferase) and directing the cyclic synthesis of NAD^± (23, 24). SIRT1 (Sirtuin1), as an NAD^±-dependent enzyme, is regulated in this manner and functions as an energy sensor by responding to the cellular levels of metabolic intermediates such as NAD^± and NADH (25). Previous studies found that SIRT1 also deacetylates transcription factors that regulate the choice of oxidative or glycolytic metabolic strategy and fatty acid synthesis, namely PPARα (peroxisome proliferator-activated receptor) and SREBP (sterol regulatory element-binding protein) (26, 27).

The desynchronization of normal circadian rhythm is associated with various pathological conditions, among which obesity and related metabolic disorders have become a concerned issue (28). The circadian desynchronization can be implemented using a homozygous CLOCK mutation model, which presents attenuated diurnal rhythm of feeding behavior and obesity (29). On the other side, diet-induced obesity (DIO) also leads to changes in the rhythmicity of core circadian clock proteins. In DIO mice, the expression of CLOCK and BMAL1 was altered associated with other metabolic disorders like leptin resistance and adiponectin deficiency (30, 31). In addition, DIO generates comprehensive rhythmic changes in the expression of proteins related to fatty acid synthesis and oxidation, especially SREBP and PPARα (32, 33). Gut microbiota analysis also reveals changes in DIO mice, characterized by a reduction in the Bacteroidetes phylum and an increase in the Firmicutes phylum (34). A few previous studies also tested the circadian rhythmicity of gut microbiota, and suggested distinct differences between normal mice and DIO mice (35–38).

The prevention and treatment for DIO has arose wide discussion, among which TRF was also intensely studied as a non-pharmaceutical intervention. It has been shown that TRF, by merely changing the external rhythm of feeding, can protect against obesity, inflammation and hepatic steatosis (5, 7, 39). However, the underlying mechanism of TRF for improving DIO-related disorders is not completely understood. It is reported that TRF can alter the hepatic expression level of core circadian proteins and mRNAs at certain timepoints of the day, resulting in changes in the circadian rhythmicity (13). And gut microbiota is reported to be another possible mechanism, as TRF decreases Firmicutes abundance and increases Bacteroidetes abundance (36, 40). In the present study, we subjected mice to TRF regimen of a high-fat diet for 8 h per day and explored the regulatory effects of TRF on weight gain and the circadian rhythmicity of hepatic lipid metabolism and gut microbiota. Our findings provided deeper understanding into the use of TRF as a non-pharmaceutical intervention.

Methods

Animals

All animal experiments were carried out in accordance with the guidelines of the Animal Care and Use Committee of the Salk Institute, and permitted by the Animal Welfare Committee of Peking Union Medical College Hospital (approval XHDW-2017-00). A total of sixty male Kunming mice at 8 weeks of age were housed five to a cage under a 12-h light/dark schedule for the experimental period of 8 weeks. All mice were provided by Academy of Military Medical Sciences, Beijing, China.

Feeding Schedule and Diets

All mice were randomly assigned to three feeding schedules: (1) normal diet-ad libitum (NA group), (2) high-fat diet (HFD)-ad libitum (FA group), and (3) HFD-TRF (FT group). All mice were fed normal diet before the experimental period. Normal-diet mice were fed a standard chow diet (D12450B; 20% protein, 10% fat, 70% carbohydrates; Research Diets, Inc., New Brunswick, NJ, United States) with unrestricted access. The other groups received HFD (D12492; 20% protein, 59.9% fat, 20.1% carbohydrates; Research Diets, Inc.) with either ad libitum access or during an 8-h window between Zeitgeber time (ZT) 16 and ZT24 every day. All mice were maintained on the experimental feeding regimens for 8 weeks and body mass was weighed weekly. Access to food was controlled by providing and removing the diet tray daily. The mass of remaining food was measured and recorded daily for every cage, and average daily calorie intake was calculated by the following formula: (original food mass-remaining food mass) × calorie-mass ratio/total number of mice. The light was turned on at ZT0 and turned off at ZT 12. More details about the diet were available upon request.

Tissue Collection and Measurement of Liver Metabolites

Twenty mice from each group were sacrificed over a 24-h period at ZT0, ZT8, ZT12, and ZT20 (five mice at each ZT timepoint). Mice fed ad libitum were sacrificed after a fasting period to keep in accordance with FT mice. Livers and rectums were collected using laparotomy. Liver lobes were separated and the median lobes were fixed in 4% buffered formalin. Other liver lobes were homogenized to test liver lipid metabolites. Rectal contents were snap-frozen and stored at −80°C prior to analysis.

Measurement of Serum Metabolites

Blood samples were collected from eight mice from each group at the end of the experimental period (two mice at each ZT timepoint). Samples were snap-frozen and stored at −80°C prior to analysis. Serum metabolites representing liver function parameters and lipid profile were quantified by automatic chemistry analyzer (Chemray 240; Rayto Life and Analytical Sciences Co., Shenzhen, China).

Liver Morphometric Analysis

Formalin-fixed liver tissues were dehydrated and embedded in optimal cutting temperature compound. Ten-micrometer sections were cut and stained with freshly prepared Oil Red O. Five mice from each group were used for the morphometric evaluation of liver steatosis. The sections were evaluated under light microscopy by two independent pathologists who were blinded to the groupings. Liver steatosis was graded by its magnitude as described previously (41). Briefly, the degree of steatosis was graded by the percentage of the liver section that was occupied by fat vacuoles at 100× magnification in 10 fields for every mouse (grade 0: ≤5%; grade 1: 5–25%; grade 2: 26–50%; grade 3: 51–75%; grade 4: >75%).

Western Blots

Whole cell protein was extracted from frozen liver tissue, and total protein lysates were subjected to SDS-PAGE on 8–20% acrylamide gels, electro-transferred to polyvinylidene difluoride membranes (MilliporeSigma, Burlington, MA, United States), and probed overnight at 4°C in the presence of the following primary antibodies: anti-SIRT1 (1:1,000, 13161-1-ap, Proteintech Group, Inc., Rosemont, IL, United States), anti-PPARα (1:1,000, ab8934, Abcam, Cambridge, United Kingdom), and anti-SREBP (1:1,000, bs-1402R, Bioss Antibodies, Woburn, MA, United States). For protein detection, we used horseradish peroxidase-conjugated secondary antibodies (Wuhan ServiceBio Technology Co., Wuhan, China). Five samples per group per timepoint were assayed; protein levels were normalized to β-actin (1:3,000, GB12001, Wuhan ServiceBio Technology Co.). Densitometry analysis of protein bands was conducted using the open-source image processing software ImageJ (https://imagej.net/ImageJ).

RNA Extraction and Quantitative RT-PCR

Total RNA was extracted from liver tissues using a RNeasy mini kit (Qiagen, Hilden, Germany). RNA concentrations were determined by spectrophotometric trace (NanoDrop, Thermo Fisher Scientific, Waltham, MA, United States). Total RNA (200–1,000 ng) was transcribed into cDNA (volume: 20 μL) using a RevertAid First Strand cDNA Synthesis Kit (#K1622, Thermo Fisher Scientific) following the manufacturer's instructions. We then used FastStart Universal SYBR Green Master (04913914001, Roche, Basel, Switzerland) to determine the relative abundance of the mRNAs of interest. The following primers were used: (a) Per1; accession number NM_001159367.2, forward 5′-GGCCAGATTGGTGGAGGTTA-3′ and reverse 5′-TCTGACTGCTGCGGGTGAT-3′; (b) Cry1; accession number NM_007771.3, forward 5′-CAGGAGGAGAAACTGAGGCACT-3′ and reverse 5′-GCCACAGGAGTTGCCCATAA-3′; (c) Bmal1; accession number NM_001243048.1, forward 5′-GGGGAAATACGGGTGAAATCTA-3′ and reverse 5′-CTGAACCATCGACTTCGTAGCG-3′. PCR reactions were performed in a total volume of 25 μL containing 2.5 μL of diluted cDNA or a reference cDNA sample. The PCR conditions were 95°C for 5 min, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. Cycles were analyzed by StepOnePlus software (ABI, Foster City, CA, United States). The PCR reaction was followed by analysis of the melting curve.

Gut Microbiota Analysis

Fecal contents of rectal samples were collected at ZT0, ZT8, ZT12, and ZT20 and preserved in −80°C refrigerator before analysis. Fecal samples were sent to Shanghai Majorbio (Shanghai, China) for 16S rRNA gene V3–V4 sequencing using a MiSeq platform (Illumina, San Diego, CA, USA). The primers used were forward 5′-ACTCCTACGGGAGGCAGCAG-3′ and reverse 5′- GGACTACHVGGGTWTCTAAT-3′. The full report and statistical analysis from Second Genome are available upon request. The original contributions presented in the study are publicly available. This data is available via SRA with BioProject number PRJNA673908.

Statistical Analysis

All statistical analyses were performed in SPSS version 24.0 (IBM SPSS, Armonk, NY, United States). The data were first subjected to normality tests. For data passing these tests, the differences between groups and differences between different ZT timepoints within same feeding regimen were analyzed by one-way ANOVA followed by the Bonferroni multiple comparison test. The differences between ZT timepoints were used to evaluate the circadian rhythmicity. Analyses were two-sided. Quantitative, continuous data are expressed as the mean ± SEM in the figures, unless noted otherwise. p < 0.05 was considered statistically significant.

Results

TRF Prevents HFD-Induced Weight Gain and Improves Serum Lipid Profile

Eight-week-old male wildtype Kunming mice were fed a normal diet ad libitum, HFD ad libitum, or HFD with TRF for an experimental period of 8 weeks. As shown in Figure 1, FA mice consumed less calories than NA mice (18.46 ± 0.98 vs. 30.3 ± 0.47 kcal/day, p < 0.001) but gained more weight (16.25 ± 5.80 vs. 12.47 ± 2.61 g, p = 0.003) during the experimental period. Compared to FA mice, FT mice consumed similar amounts of calories (19.33 ± 1.11 kcal/day, p = 0.335) but gained less weight (12.72 ± 5.04 g, p = 0.006).

FIGURE 1

Figure 1. Effects of feeding regimen on calorie intake and body weight. Food intake and body weights were measured weekly. (A) Calorie intake for every week; (B) Average calorie intake for the 8 weeks; (C) Body weights at every week. Data were shown as mean ± SEM (n = 20 for each group). Data were analyzed by one-way ANOVA followed by Bonferroni multiple comparison test. In (A) *FA vs. NA, p < 0.05 and FT vs. NA, p < 0.05. In (B), compared to the NA group, *p < 0.05. In (C), compared to the NA group, *p < 0.05 (green and blue asterisks represent for FA and FT group, respectively), compared to the FA group, #p < 0.05. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet.

We then examined the effects of feeding regimen on serum metabolites. Serum levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) were different between groups (see Additional File S1). Compared to NA mice, FA mice had a higher level of LDL-C and comparable serum levels of TC and TG. FT mice had a lower level of TG (0.54 ± 0.09 mmol/L) compared to both NA (0.82 ± 0.05 mmol/L, p = 0.017) and FA mice (0.77 ± 0.28 mmol/L, p = 0.036). And no significant differences were observed between groups regarding levels of albumin, alanine aminotransferase or bilirubin.

TRF Alleviates Liver Steatosis and Decreases Hepatic TG Level

We then investigated whether feeding regimens influenced the severity of liver steatosis. Median lobes of the liver were formalin-fixed and sectioned to assess liver steatosis. As shown in Figure 2A, FA mice had a large numbers of fat vacuoles in the liver section in contrast with NA and FT mice. Liver steatosis was graded in 5 mice from each group (Figure 2B). FA mice had a higher grading of liver steatosis than NA mice, and FT mice had a lower grading of liver steatosis than FA mice while comparable to NA mice.

FIGURE 2

Figure 2. Effects of feeding regimen on liver steatosis. (A) Representative images of hematoxylin and eosin-stained and Oil Red O-stained liver tissue sections from three experimental groups. Slides were photographed at a magnification of 200×. Scale Bar = 50 μm. (B) Liver steatosis grading (n = 5). (C) Hepatic TG levels (n = 20). Data were shown as mean ± SEM. Data were analyzed using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, *p < 0.01. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; TG, triglyceride.

We then tested hepatic lipid levels using liver homogenates at different ZT timepoints. Compared to NA mice, both FA mice and FT mice had higher overall hepatic levels of TG, TC, LDL-C, and HDL-C (Figure 2C and Additional File S2). FT mice had a lower hepatic TG level than FA mice (0.267 ± 0.084 vs. 0.363 ± 0.031 mmol/L, p = 0.011). The overall hepatic levels of other lipid metabolites of FT mice were comparable to FA mice.

Despite changes in the overall hepatic TG level, FA mice, and FT mice did not exhibit significant fluctuations among different ZT timepoints (see Additional File S3). The differences of the four tested hepatic lipid levels between ZT timepoints were not significant in any group, except for the hepatic LDL-C level of NA mice (p = 0.030). The hepatic TG levels of FA mice were higher than NA mice at all four ZT timepoints. And FT mice had intermediate hepatic TG levels compared to both NA and FA mice at all four timepoints, while the differences between FT and NA mice were not significant.

TRF Changes Gut Microbiota Composition at Certain ZT Timepoints

To further investigate how feeding regimen influences serum and hepatic lipid profiles, we tested the composition and richness of gut microbiota from mice of all three groups at different ZT timepoints. Fecal samples were collected and genomic DNA was extracted from fecal samples and sequenced to identify various bacterial taxa. A total of 672 filtered operational taxonomic units (OTUs) were detected. Principal component analysis (PCA) of bacteria demonstrated a separation between NA group and the other two groups, while FA group and FT group were close to each other (Figure 3A). Sample richness was compared between groups using Chao and Ace indexes (Figures 3B,C). Compared to NA mice, FA mice had a lower Chao index (p = 0.013) and Ace index (p = 0.006). And the differences between FT mice and NA mice were not significant, regarding both Chao index (p = 0.190) and Ace index (p = 0.073).

FIGURE 3

Figure 3. The effects of feeding regimen on the diversity of gut microbiota. (A) Principal component analysis (PCA) of beta diversity on OTU level. (B) Alpha diversity by Chao index. (C) Alpha diversity by ACE index. Data were shown as mean ± SEM (n = 16–20 for each group). Indexes were compared using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, *p < 0.05. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; OTU, operational taxonomic unit.

The composition of gut microbiota is also different between groups (Figure 4). Compared to NA mice, FA mice had a higher relative abundance of Firmicutes (58.04 ± 9.33% vs. 34.10 ± 13.49%, p < 0.001) and Proteobacteria (10.81 ± 11.23% vs. 2.34 ± 1.38%, p = 0.002), and a lower relative abundance of Bacteroidetes (27.02 ± 13.06% vs. 61.34 ± 12.99%, p < 0.001). And FT mice had an intermediate relative abundance of Firmicutes (47.89 ± 12.86%) and Bacteroidetes (39.28 ± 17.08%) compared to NA and FA mice (see Additional File S4).

FIGURE 4

Figure 4. The effects of feeding regimen on gut microbiome composition at different ZT timepoints. Four predominant phyla were presented: (A) Bacteroidetes, (B) Firmicutes, (C) Actinobacteria, and (D) Proteobacteria. Relative abundance levels of phyla were shown as mean ± SEM (%) (n = 4–5 for each timepoint; n = 18–20 for the average). Data were compared between groups at same ZT timepoints using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, *p < 0.05, **p < 0.01, ***p < 0.001. Data were also compared between different ZT timepoints within same feeding regimen using one-way ANOVA, ^⋆p < 0.05, ^⋆⋆p < 0.01. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; ZT, Zeitgeber time.

To investigate whether the composition of gut microbiota is circadian rhythmically dependent, data were compared between different ZT timepoints (Figure 4). The abundance of Actinobacteria was diurnally fluctuated in all three groups, and the abundance levels of Bacteroidetes and Firmicutes were diurnally fluctuated (p = 0.003 and 0.006, respectively), in FT mice (Figures 4A–C). Compared to NA mice, both FA and FT mice had a lower Bacteroidetes abundance level and a higher Firmicutes abundance level at ZT0 and ZT12, and the differences at ZT8 and ZT20 were not significant (Figures 4A,B). Compared to FA mice, FT mice had a higher Bacteroidetes abundance level at ZT20 (57.58 ± 10.77% vs. 29.27 ± 11.56%, p = 0.029) and a lower Firmicutes level at ZT20 (35.04 ± 9.38% vs. 52.77 ± 7.73%, p = 0.026). And FT mice had a slightly higher Bacteroidetes abundance level and lower Firmicutes abundance level at other timepoints compared to FA mice, but the differences were not significant. The abundance levels of several subphylum categories were analyzed and compared between ZT timepoints (see Additional File S5). The relative abundance of family Lachnospiraceae showed oscillation between timepoints in NA and FT mice (p = 0.010 and 0.045, respectively), but not in FA mice (p = 0.2769). Abundance levels of family Ruminococcacea also showed a circadian rhythm in NA and FT mice (p = 0.012 and 0.037, respectively), while no rhythm in FA mice (p = 0.249).

TRF Alters the Circadian Expression of Proteins Related to Lipid Metabolism in Liver

In order to investigate whether feeding regimens affect the hepatic expression of proteins involved in energy and lipid metabolism, we tested the whole cell protein levels of SIRT1, SREBP, and PPARα (Figures 5A–C,G). In NA mice, the hepatic protein levels of SIRT1 and PPARα exhibited clear circadian rhythms (p = 0.004 and 0.048, respectively), while the protein levels of SREBP were comparable between different timepoints. In NA mice, the circadian rhythm of SIRT1 expression manifested as peaking at ZT12 and reaching bottom at ZT0, with a peak-to-valley ratio of 6.08. Such rhythm disappeared in FA mice (p = 0.906) and was restored in FT mice (p = 0.049), with a peak-to-valley ratio of 3.61. Regarding differences between groups, however, FT mice had comparable cellular protein levels of SIRT1 compared to FA mice at ZT8 and ZT12, both of which were lower than NA mice (Figure 5A). Both FA and FT mice exhibited clear circadian rhythms of SREBP expression (p < 0.001 for both groups, Figure 5B). The rhythms of FA mice and FT mice were similar, presented as peaking at ZT20 and reaching bottom at ZT0, with peak-to-valley ratios of 6.58 and 4.78, respectively. Regarding group comparisons, FA mice had a higher SREBP amount at ZT12 (p = 0.033) while FT mice had a comparable SREBP amount (p = 0.511) compared to NA mice. Both FT and FA mice had higher amounts of SREBP at ZT20 compared to NA mice, while that of FT mice was significantly lower than FA mice (p = 0.008). The expression of PPARα in NA mice peaked at ZT8 and reached bottom at ZT20, with a peak-to-valley ratio of 3.25 (Figure 5C). Such circadian rhythm was also observed in FT mice but not in FA mice. Regarding group comparisons, cellular amounts of PPARα were elevated FA mice at ZT0 (p < 0.001) and ZT20 (p = 0.044) compared to NA mice. Such differences were not observed in FT mice compared to NA mice, and FT mice had a lower amount of PPARα at ZT0 compared to FA mice (p = 0.004).

FIGURE 5

Figure 5. The effects of feeding regimen on hepatic circadian genes. Hepatic levels of proteins (A–C,G) and mRNAs (D–F) related to circadian rhythm or energy metabolism. Livers were isolated by laparotomy in each group, and the whole cell protein levels of SIRT1, SREBP, and PPARα were measured by Western blotting: (A) SIRT1, Sirtuin1; (B) SREBP, Sterol Regulatory Element Binding Protein; (C) PPARα, Peroxisome Proliferator-activated Receptor α. Relative mRNA expressions were tested using real-time qPCR: (D) Per1 mRNA; (E) Cry1 mRNA; (F) Bmal1 mRNA. Relative amounts of proteins (relative to β-actin) or mRNAs were shown as mean ± SEM. (G) The representative image of immunoblotting analysis of lysates from liver tissue. Data were shown as mean ± SEM (n = 4–5 for each timepoint). Data were compared between groups at same ZT timepoints using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, *p < 0.05, **p < 0.01, ***p < 0.001. Data were also compared between different ZT timepoints within same feeding regimen using one-way ANOVA, ^⋆p < 0.05, ^⋆⋆p < 0.01. FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; NA, mice fed a normal diet ad libitum; ZT, Zeitgeber time.

TRF Mildly Alters the Circadian Expression of Endogenous Core Clock Genes in Liver

To examine whether TRF also affected the expression of endogenous circadian genes, we tested hepatic mRNA amounts of Per1, Cry1, and Bmal1 using real-time qPCR (Figures 5D–F). The expression of Per1, Cry1, and Bmal1 exhibited clear circadian rhythm in all three groups. Per1 expression peaked at ZT12 and reached bottom at ZT0 in NA mice, with a peak-to-valley ratio of 1.99. Cry1 and Bmal1 expression peaked at ZT0 and reached bottom at ZT12 in NA mice, with peak-to-valley ratios of 13.59 and 12.23, respectively. Both FA and FT mice exhibited similar circadian rhythms of Per1 expression compared to NA mice, peaking at ZT12 and reaching bottom at ZT0, with peak-to-valley ratios of 6.51 and 4.77, respectively (Figure 5D). Regarding group comparisons, Per1 levels were consistently lower in FA mice compared to NA mice at all four timepoints. Compared to NA mice, FT mice had lower Per1 levels at ZT0 and ZT20, and comparable Per1 levels at ZT8 and ZT12, which were higher than FA mice. FA and FT mice presented different circadian rhythms of Cry1 expression from NA mice, peaking at ZT20, and reaching bottom at ZT12, with peak-to-valley ratios of 26.34 and 18.31, respectively (Figure 5E). Regarding group comparisons, both FA and FT mice had a lower Cry1 level at ZT0 and a higher Cry1 level at ZT20 compared to NA mice, while Cry1 levels were comparable at ZT8 and ZT12. Regarding Bmal1 level, FA, and FT mice presented different circadian rhythms from NA mice, peaking at ZT20 instead of ZT0, with peak-to-valley ratios of 10.49 and 5.13, respectively (Figure 5F). Compared to NA mice, both FA and FT mice had lower Bmal1 levels at ZT0, which was the peak of NA mice.

Discussion

TRF, also known as intermittent fasting, by merely restricting nutrient intake into certain hours of the day with no limitation on nutrient quality or quantity, has been widely reported to not only extend life span, but also protect against various pathological conditions, including HFD-induced obesity and related metabolic disorders (1–5, 42, 43). However, the underlying mechanism of how TRF improves DIO-related disorders is not completely understood. Therefore, the present study aimed to investigate the effects of TRF on the circadian rhythmicity of hepatic lipid metabolism and gut microbiota in mice.

In the present study, under HFD feeding, FA mice showed more weight gain despite less calorie intake, which may be attributed to less increase in the post-prandial metabolic rate (44). FA mice also exhibited significant liver steatosis and elevated hepatic levels of TG compared to NA mice, indicating the HFD-induced obesity mice model was well-established in the study. And implementation of TRF in mice fed HFD protected against obesity and hepatic lipid accumulation, presented with decreased weight gain, severity of liver steatosis, and hepatic TG level compared to FA mice, which was consistent with previous studies in rodent animals (7, 36, 42, 45). Therefore, it was reasonable to further investigate the underlying mechanism of TRF using the well-established HFD-TRF mice model in the present study. And we mainly focused on changes on gut microbiota and hepatic lipid metabolism.

Changes in gut microbiota, characterized by increased Firmicutes and Actinobacteria abundance and decreased Bacteroidetes abundance, as well as absence of daily oscillations in the relative abundance of family Lachnospiraceae and Ruminococcaceae, have been shown to be associated with DIO in rodent animals (34, 37, 46, 47). Our study reported that TRF resulted in an increase in sample richness, an increase in Bacteroidetes abundance and a decrease in Firmicutes abundance, which was consistent with previous knowledge. Some studies suggested that the gut microbiota composition oscillated in a diurnal pattern in wildtype mice, though the exact oscillation regularities of specific phyla were not well-studied (35, 36). Our study depicted the oscillation pattern of abundance of Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria using differences between four distinct ZT timepoints and found TRF led to clear oscillation patterns in Bacteroidetes and Firmicutes. Subphylum analysis on the relative abundance of family Lachnospiraceae and Ruminococcaceae found significant oscillations in NA mice and FT mice, but not in FA mice, suggesting such circadian rhythms exhibited in NA mice were disturbed by HFD feeding and further restored by TRF. In our study, the circadian rhythm in FT mice is characterized by a prominent increase of Bacteroidetes and decrease of Firmicutes at ZT20, which was not observed in the other two groups. Considering the feeding window of FT mice was restricted between ZT16 and ZT24, ZT20 basically represented the feeding phase in TRF. Therefore, such oscillation patterns indicated a distinct difference triggered by TRF regimen between feeding and fasting phases.

We then tested the hepatic expression of core circadian clock genes (Per1, Cry1, and Bmal1) and proteins related to lipid metabolism (SIRT1, SREBP, and PPARα) to further understand the molecular mechanism of TRF. The core circadian feedback circuits composed of CLOCK, BMAL1, PER, and CRY maintain the cell-autonomous circadian rhythm, and further regulate cellular metabolism through intermediate proteins including SIRT1, SREBP, and PPARα (48–53). Previous knowledge regarding the oscillation pattern of mRNA Per1, Cry1, and Bmal1 all manifested clear diurnal rhythms with one peak and one bottom, though the specific patterns were not completely consistent (7, 45, 52, 54). In our study, the circadian rhythmicity in NA mice was comparable to previous studies with similar peak and bottom timepoints (7, 45). Comparison between the three experimental groups showed similar oscillation patterns of Per1, Cry1, and Bmal1 between FT and FA mice though the relative amounts were slightly different, and both FT and FA mice exhibited distinct oscillation patterns for Cry1 and Bmal1 compared to NA mice. Therefore, the TRF regimen in our study did not remodel the hepatic core circadian rhythm altered by HFD to a natural rhythmicity, which indicated the core circadian clock was altered by the feeding content rather than feeding schedule.

In peripheral organs, SIRT1 regulates the oscillatory rhythms and metabolic pathways as a metabolic rheostat (51, 52). The present study showed similar circadian expression of SIRT1 in NA and FT mice, but not in FA mice, indicating TRF restored the circadian rhythm of SIRT1 expression. The protein level of SIRT1 was decreased under conditions with fewer calorie intake (FA and FT mice), and it was consistent with previous studies suggesting TRF with calorie restriction can prevent liver lipid accumulation and alleviate liver inflammation by decreasing hepatic SIRT1 level (27, 55, 56). Accumulated evidences showed SIRT1 negatively regulate SREBP and PPAR levels in the liver (27, 57–59). Our study also presented a consistent increase in both SREBP and PPARα regardless of ZT timepoints, which was possibly sequential to the changes of SIRT1. SREBP and PPAR are involved in energy metabolism and liver lipid synthesis and accumulation, and elevations in SREBP and PPAR contribute to the development of obesity (60–63). The hepatic circadian rhythm of PPARα is characterized as peak at ZT8 and bottom at ZT20 in NA mice and the rhythm disappeared in FA mice, which was exactly the situation in our study (64). Our FT mice also exhibited a similar circadian pattern of PPARα with NA mice, suggesting TRF restored the hepatic rhythm of PPARα. Regarding the hepatic rhythm of SREBP, no clear pattern was found in NA mice, while FA mice had a profoundly higher level at ZT20. Though FT mice also exhibited significant differences between ZT timepoints, its SREBP level at ZT20 was lower than that of FA mice. It indicated that TRF reduced the HFD-induced elevation of SREBP at ZT20, but was not able to restore it to a natural condition. Previous studies have suggested the relationship between hepatic metabolism and gut microbiota using fecal microbiota transplantation. In DIO and HFD-TRF mice, changes in the gut microbiota directly altered the metabolism and absorption of fatty acid, which further induced adiposity by stimulating hepatic de novo lipogenesis and triglyceride storage through SREBP (46, 65). However, the causal relationship between changes in the gut microbiota and hepatic lipid metabolism, as well as the reasons for body mass changes under TRF condition needs further exploration, where metabolic cages and MR imaging shall be used in further researches.

Herein, our study further demonstrated the beneficial effects of TRF, that TRF altered the average abundance of the gut microflora, as well as the circadian rhythm of proteins related to hepatic lipid metabolism. It suggested this feeding regimen might improve metabolism and restructure circadian rhythms as a non-pharmacological intervention to prevent obesity by modulating the circadian rhythm.

Conclusions

In general, we demonstrated that TRF had protective effects against DIO-related disorders. It mainly functioned by influencing gut microbiota and hepatic metabolism, especially by restoring the circadian rhythm of gut microbiota composition and hepatic lipid metabolism. These findings provide deeper insight into the use of TRF as a non-pharmacological intervention.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The animal study was reviewed and approved by the Animal Welfare Committee of Peking Union Medical College Hospital.

Author Contributions

YY, HX, and YM: study conception and design. YM: funding acquisition. ZX, LW, and YS: acquisition of data. YY, DH, and HY: statistical analysis. YY, HX, and DH: analysis and interpretation of data. YY: drafting of manuscript. DH and YM: critical revision. All authors: approved the final version of the article, including the authorship list.

Funding

The study was supported by grants from the CAMS Innovation Fund for Medical Sciences (CIFMS) (Grant No. 2017-I2M-1-001).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This manuscript has been released as a pre-print at Research Square, which can be found at doi: 10.21203/rs.3.rs-25676/v1.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2020.596285/full#supplementary-material

Additional File S1. Effects of feeding regimen on serum metabolites summarizes levels of serum metabolites of the three groups.

Additional File S2. Effects of feeding regimen on hepatic lipid levels summarizes overall hepatic levels of TG, TC, LDL-C, and HDL-C of the three groups.

Additional File S3. Effects of feeding regimens on hepatic lipid levels at different ZT timepoints summarizes hepatic levels of TG, TC, LDL-C, and HDL-C of the three groups at ZT0, ZT8, ZT12, and ZT20. Effects of feeding regimen on hepatic lipid levels. (A) Triglycerides (TG). (B) Total cholesterol (TC). (C) Low-density lipoprotein cholesterol (LDL-C). (D) High-density lipoprotein cholesterol (HDL-C). Data were shown as mean ± SEM (n = 5 for each column). Data were compared between groups at same ZT timepoints using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, ^*p < 0.05, ^**p < 0.01. Data were also compared between different ZT timepoints within same feeding regimen using one-way ANOVA, ^⋆p < 0.05. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; ZT, Zeitgeber time.

Additional File S4. Effects of feeding regimen on gut microbiota composition summarizes the abundance levels of 4 predominant phyla in gut microbiota of the three groups.

Additional File S5. Effects of feeding regimen on gut microbiome composition at different ZT timepoints (analyzed on subphylum level). Presents the relative abundance levels of 3 categories of interest. Effects of feeding regimen on gut microbiota. (A) family Lachnospiraceae. (B) family Ruminococcus. (C) genus Lactococcus. Relative abundance levels were shown as mean ± SEM (%) (n = 4–5 for each timepoint; n = 18–20 for the average). Data were compared between groups at same ZT timepoints using one-way ANOVA followed by Bonferroni multiple comparison test. Compared to NA group, ^*p < 0.05, ^**p < 0.01, ^***p < 0.001. Data were also compared between different ZT timepoints within same feeding regimen using one-way ANOVA, ^⋆p < 0.05. NA, mice fed a normal diet ad libitum; FA, mice fed a high-fat diet ad libitum; FT, mice fed a time-restricted high-fat diet; ZT, Zeitgeber time.

References

1. de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. (2019) 381:2541–51. doi: 10.1056/NEJMra1905136

CrossRef Full Text | Google Scholar

2. Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. (2018) 27:1212–21.e3. doi: 10.1016/j.cmet.2018.04.010

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr. (1986) 116:641–54. doi: 10.1093/jn/116.4.641

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel deaconess medical center. Caloric intake and aging. N Engl J Med. (1997) 337:986–94. doi: 10.1056/NEJM199710023371407

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Adamovich Y, Rousso-Noori L, Zwighaft Z, Neufeld-Cohen A, Golik M, Kraut-Cohen J, et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell Metab. (2014) 19:319–30. doi: 10.1016/j.cmet.2013.12.016

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Chaix A, Zarrinpar A. The effects of time-restricted feeding on lipid metabolism and adiposity. Adipocyte. (2015) 4:319–24. doi: 10.1080/21623945.2015.1025184

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong Eric A, Gill S, et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. (2012) 15:848–60. doi: 10.1016/j.cmet.2012.04.019

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Rivera-Zavala JB, Molina-Aguilar C, Pérez-Mendoza M, Olguín-Martínez M, Hernández-Muñoz R, Báez-Ruiz GA, et al. Daytime restricted feeding modifies the daily regulation of fatty acid β-oxidation and the lipoprotein profile in rats. Br J Nutr. (2017) 117:930–41. doi: 10.1017/S0007114517000800

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Hu D, Mao Y, Xu G, Liao W, Yang H, Zhang H. Gut flora shift caused by time-restricted feeding might protect the host from metabolic syndrome, inflammatory bowel disease and colorectal cancer. Transl Cancer Res. (2018) 7:1282–9. doi: 10.21037/tcr.2018.10.18

CrossRef Full Text | Google Scholar

10. Mattson MP. An evolutionary perspective on why food overconsumption impairs cognition. Trends Cogn Sci. (2019) 23:200–12. doi: 10.1016/j.tics.2019.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Ren J, Hu D, Mao Y, Yang H, Liao W, Xu W, et al. Alteration in gut microbiota caused by time-restricted feeding alleviate hepatic ischaemia reperfusion injury in mice. J Cell Mol Med. (2019) 23:1714–22. doi: 10.1111/jcmm.14069

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Mirmiran P, Teymoori F, Asghari G, Azizi F. Diet quality and nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr. (2019) 8:262–3. doi: 10.21037/hbsn.2018.12.14

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Patel SA, Velingkaar N, Makwana K, Chaudhari A, Kondratov R. Calorie restriction regulates circadian clock gene expression through BMAL1 dependent and independent mechanisms. Sci Rep. (2016) 6:25970. doi: 10.1038/srep25970

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Challet E, Mendoza J, Dardente H, Pevet P. Neurogenetics of food anticipation. Euro J Neurosci. (2009) 30:1676–87. doi: 10.1111/j.1460-9568.2009.06962.x

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. (2008) 9:764–75. doi: 10.1038/nrg2430

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell. (2008) 134:728–42. doi: 10.1016/j.cell.2008.08.022

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Okamura H. Clock genes in cell clocks: roles, actions, and mysteries. J Biol Rhythms. (2004) 19:388–99. doi: 10.1177/0748730404269169

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. (2012) 35:445–62. doi: 10.1146/annurev-neuro-060909-153128

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell. (2002) 111:919–22. doi: 10.1016/S0092-8674(02)01225-4

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Crane BR, Young MW. Interactive features of proteins composing eukaryotic circadian clocks. Annu Rev Biochem. (2014) 83:191–219. doi: 10.1146/annurev-biochem-060713-035644

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Asher G, Sassone-Corsi P. Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock. Cell. (2015) 161:84–92. doi: 10.1016/j.cell.2015.03.015

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, et al. Reprogramming of the circadian clock by nutritional challenge. Cell. (2013) 155:1464–78. doi: 10.1016/j.cell.2013.11.034

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science. (2009) 324:654–7. doi: 10.1126/science.1170803

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science. (2009) 324:651–4. doi: 10.1126/science.1171641

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Guarente L. Sirtuins, aging, and metabolism. Cold Spring Harb Symp Quant Biol. (2011) 76:81–90. doi: 10.1101/sqb.2011.76.010629

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. (2009) 9:327–38. doi: 10.1016/j.cmet.2009.02.006

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. (2005) 434:113–8. doi: 10.1038/nature03354

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Challet E. Keeping circadian time with hormones. Diabetes Obes Metab. (2015) (17 Suppl. 1):76–83. doi: 10.1111/dom.12516

CrossRef Full Text | Google Scholar

29. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science. (2005) 308:1043–5. doi: 10.1126/science.1108750

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Xie X, Yang S, Zou Y, Cheng S, Wang Y, Jiang Z, et al. Influence of the core circadian gene “clock” on obesity and leptin resistance in mice. Brain Res. (2013) 1491:147–55. doi: 10.1016/j.brainres.2012.11.007

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Kaneko K, Yamada T, Tsukita S, Takahashi K, Ishigaki Y, Oka Y, et al. Obesity alters circadian expressions of molecular clock genes in the brainstem. Brain Res. (2009) 1263:58–68. doi: 10.1016/j.brainres.2008.12.071

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Guan D, Xiong Y, Borck PC, Jang C, Doulias PT, Papazyan R, et al. Diet-induced circadian enhancer remodeling synchronizes opposing hepatic lipid metabolic processes. Cell. (2018) 174:831–42.e12. doi: 10.1016/j.cell.2018.06.031

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Oster H. Circadian enhancer profiling in diet-induced obese mice reveals a critical time window for lipid-lowering therapies. Hepatobiliary Surg Nutr. (2019) 8:280–2. doi: 10.21037/hbsn.2019.01.19

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. (2008) 3:213–23. doi: 10.1016/j.chom.2008.02.015

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. (2014) 159:514–29. doi: 10.1016/j.cell.2014.09.048

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Zarrinpar A, Chaix A, Yooseph S, Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. (2014) 20:1006–17. doi: 10.1016/j.cmet.2014.11.008

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Leone V, Gibbons SM, Martinez K, Hutchison AL, Huang EY, Cham CM, et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe. (2015) 17:681–9. doi: 10.1016/j.chom.2015.03.006

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Gui L, Chen S, Wang H, Ruan M, Liu Y, Li N, et al. ω-3 PUFAs alleviate high-fat diet-induced circadian intestinal microbes dysbiosis. Mol Nutr Food Res. (2019) 63:e1900492. doi: 10.1002/mnfr.201900492

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Chaix A, Zarrinpar A, Miu P, Panda S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. (2014) 20:991–1005. doi: 10.1016/j.cmet.2014.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Hu D, Mao Y, Xu G, Liao W, Ren J, Yang H, et al. Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice. Pediatr Res. (2019) 85:518–26. doi: 10.1038/s41390-018-0156-z

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Stice CP, Liu C, Aizawa K, Greenberg AS, Ausman LM, Wang XD. Dietary tomato powder inhibits alcohol-induced hepatic injury by suppressing cytochrome p450 2E1 induction in rodent models. Arch Biochem Biophys. (2015) 572:81–8. doi: 10.1016/j.abb.2015.01.004

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Chung H, Chou W, Sears DD, Patterson RE, Webster NJ, Ellies LG. Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity. Metabolism. (2016) 65:1743–54. doi: 10.1016/j.metabol.2016.09.006

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. (2017) 9:eaai8700. doi: 10.1007/978-94-024-1045-7

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Nair KS, Halliday D, Garrow JS. Thermic response to isoenergetic protein, carbohydrate or fat meals in lean and obese subjects. Clin Sci. (1983) 65:307–12. doi: 10.1042/cs0650307

CrossRef Full Text | Google Scholar

45. Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. (2012) 26:3493–502. doi: 10.1096/fj.12-208868

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. (2004) 101:15718–23. doi: 10.1073/pnas.0407076101

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. (2011) 334:105–8. doi: 10.1126/science.1208344

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Reddy AB, O'Neill JS. Healthy clocks, healthy body, healthy mind. Trends Cell Biol. (2010) 20:36–44. doi: 10.1016/j.tcb.2009.10.005

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell. (2001) 107:855–67. doi: 10.1016/S0092-8674(01)00610-9

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell. (2006) 125:497–508. doi: 10.1016/j.cell.2006.03.033

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell. (2008) 134:329–40. doi: 10.1016/j.cell.2008.07.002

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. (2008) 134:317–28. doi: 10.1016/j.cell.2008.06.050

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Oishi K, Shirai H, Ishida N. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. Biochem J. (2005) 386:575–81. doi: 10.1042/BJ20041150

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Chen R, Zuo Z, Li Q, Wang H, Li N, Zhang H, et al. DHA substitution overcomes high-fat diet-induced disturbance in the circadian rhythm of lipid metabolism. Food Funct. (2020) 11:3621–31. doi: 10.1039/C9FO02606A

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL, et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol. (2009) 11:492–500. doi: 10.1038/ncb1857

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Chen D, Bruno J, Easlon E, Lin SJ, Cheng HL, Alt FW, et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. (2008) 22:1753–7. doi: 10.1101/gad.1650608

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. (2010) 24:1403–17. doi: 10.1101/gad.1901210

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. (2004) 429:771–6. doi: 10.1038/nature02583

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. (2008) 582:46–53. doi: 10.1016/j.febslet.2007.11.034

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. (2002) 109:1125–31. doi: 10.1172/JCI0215593

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Walker AK, Jacobs RL, Watts JL, Rottiers V, Jiang K, Finnegan DM, et al. A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell. (2011) 147:840–52. doi: 10.1016/j.cell.2011.09.045

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. (1999) 103:1489–98. doi: 10.1172/JCI6223

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA. (1999) 96:7473–8. doi: 10.1073/pnas.96.13.7473

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Tognini P, Murakami M, Liu Y, Eckel-Mahan KL, Newman JC, Verdin E, et al. Distinct circadian signatures in liver and gut clocks revealed by ketogenic diet. Cell Metab. (2017) 26:523–38.e5. doi: 10.1016/j.cmet.2017.08.015

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. (2006) 444:1027–31. doi: 10.1038/nature05414

PubMed Abstract | CrossRef Full Text | Google Scholar